Esserman LJ - Search Results

1

Imaging features of HER2 overexpression in breast cancer: a systematic review and meta-analysis.

Elias SG, Adams A, Wisner DJ, Esserman LJ, van't Veer LJ, Mali WP, Gilhuijs KG, Hylton NM. Elias SG, et al. Among authors: esserman lj. Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1464-83. doi: 10.1158/1055-9965.EPI-13-1170. Epub 2014 May 7. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 24807204 Review.

2

Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability.

Kinkel K, Helbich TH, Esserman LJ, Barclay J, Schwerin EH, Sickles EA, Hylton NM. Kinkel K, et al. Among authors: esserman lj. AJR Am J Roentgenol. 2000 Jul;175(1):35-43. doi: 10.2214/ajr.175.1.1750035. AJR Am J Roentgenol. 2000. PMID: 10882243

3

MR imaging of the breast in patients with positive margins after lumpectomy: influence of the time interval between lumpectomy and MR imaging.

Frei KA, Kinkel K, Bonel HM, Lu Y, Esserman LJ, Hylton NM. Frei KA, et al. Among authors: esserman lj. AJR Am J Roentgenol. 2000 Dec;175(6):1577-84. doi: 10.2214/ajr.175.6.1751577. AJR Am J Roentgenol. 2000. PMID: 11090379

4

Integration of breast imaging into cancer management.

Esserman LJ, Wolverton D, Hylton N. Esserman LJ, et al. Curr Oncol Rep. 2000 Nov;2(6):572-81. doi: 10.1007/s11912-000-0112-y. Curr Oncol Rep. 2000. PMID: 11122895 Review.

5

Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor Histopathology and Angiogenesis in Breast Carcinoma.

Esserman L, Hylton N, George T, Weidner N. Esserman L, et al. Breast J. 1999 Jan;5(1):13-21. doi: 10.1046/j.1524-4741.1999.005001013.x. Breast J. 1999. PMID: 11348250

6

New approaches to the imaging, diagnosis, and biopsy of breast lesions.

Esserman LJ. Esserman LJ. Cancer J. 2002 May-Jun;8 Suppl 1:S1-14. Cancer J. 2002. PMID: 12075695 Review.

7

Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy.

Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Sudilovsky D, Hylton NM. Partridge SC, et al. Among authors: esserman lj. AJR Am J Roentgenol. 2002 Nov;179(5):1193-9. doi: 10.2214/ajr.179.5.1791193. AJR Am J Roentgenol. 2002. PMID: 12388497

8

Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity.

Hwang ES, Kinkel K, Esserman LJ, Lu Y, Weidner N, Hylton NM. Hwang ES, et al. Among authors: esserman lj. Ann Surg Oncol. 2003 May;10(4):381-8. doi: 10.1245/aso.2003.03.085. Ann Surg Oncol. 2003. PMID: 12734086

9

MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival.

Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Tripathy D, Wolverton DS, Rugo HS, Hwang ES, Ewing CA, Hylton NM. Partridge SC, et al. Among authors: esserman lj. AJR Am J Roentgenol. 2005 Jun;184(6):1774-81. doi: 10.2214/ajr.184.6.01841774. AJR Am J Roentgenol. 2005. PMID: 15908529

10

Biologic significance of false-positive magnetic resonance imaging enhancement in the setting of ductal carcinoma in situ.

Kumar AS, Chen DF, Au A, Chen YY, Leung J, Garwood ER, Gibbs J, Hylton N, Esserman LJ. Kumar AS, et al. Among authors: esserman lj. Am J Surg. 2006 Oct;192(4):520-4. doi: 10.1016/j.amjsurg.2006.07.003. Am J Surg. 2006. PMID: 16978965 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

433 results

Search Page

Filters